POVIDONE-IODINE

POVIDONE-IODINE was reported 4274 times

POVIDONE-IODINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AQUEOUS FIBRIN 29 0.5686
1 CSF SHUNT REMOVAL 3 0.3750
2 TOXIC ANTERIOR SEGMENT SYNDROME 287 0.2631
3 HEPATIC ENZYME 34 0.2282
4 ANTERIOR CHAMBER FIBRIN 24 0.1860
5 POLYGLANDULAR DISORDER 11 0.1618
6 TONSILLAR ULCER 23 0.1586
7 FIBRIN 6 0.1395
8 BACTERIAL ENDOPHTHALMITIS 33 0.1241
9 HYPOPYON 85 0.1027
10 FOETAL NON-STRESS TEST ABNORMAL 6 0.1000
11 PAROPHTHALMIA 20 0.0840
12 PSEUDOENDOPHTHALMITIS 8 0.0808
13 ANTERIOR CHAMBER CELL 54 0.0756
14 ENDOPHTHALMITIS 432 0.0719
15 ANAEMIA FOLATE DEFICIENCY 11 0.0570
16 RETINAL FIBROSIS 4 0.0556
17 RETINAL CYST 9 0.0542
18 EYE INFECTION INTRAOCULAR 4 0.0513
19 IODINE ALLERGY 17 0.0511
20 DELAYED DELIVERY 7 0.0493
21 ANTERIOR CHAMBER DISORDER 11 0.0478
22 BALANITIS CANDIDA 6 0.0469
23 LOWER RESPIRATORY TRACT INFECTION VIRAL 23 0.0455
24 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 8 0.0452
25 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 8 0.0442
26 NON-INFECTIOUS ENDOPHTHALMITIS 35 0.0412
27 CANDIDA ENDOPHTHALMITIS 5 0.0410
28 HAEMORRHAGIC NECROTIC PANCREATITIS 3 0.0400
29 VITREAL CELLS 8 0.0396
30 CORNEAL INFILTRATES 12 0.0382
31 RETINOPATHY OF PREMATURITY 21 0.0379
32 VITRITIS 69 0.0372
33 VITREOUS DEGENERATION 6 0.0366
34 POSTOPERATIVE INFECTION 17 0.0359
35 CORNEAL OEDEMA 79 0.0352
36 RETINAL ANEURYSM 7 0.0350
37 CUTIS LAXA 9 0.0331
38 CORNEAL EPITHELIUM DEFECT 19 0.0327
39 VITREOUS HAZE 5 0.0327
40 CATARACT NUCLEAR 21 0.0315
41 RETINAL DRUSEN 5 0.0305
42 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 11 0.0303
43 RETINOGRAM ABNORMAL 8 0.0299
44 CATARACT OPERATION COMPLICATION 15 0.0295
45 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 25 0.0281
46 EYE NAEVUS 3 0.0263
47 PUNCTATE KERATITIS 24 0.0261
48 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 32 0.0257
49 CONJUNCTIVAL OEDEMA 26 0.0253
50 IRIS ATROPHY 5 0.0242
51 RETINAL SCAR 11 0.0239
52 ANTERIOR CHAMBER INFLAMMATION 14 0.0235
53 HYPOCHOLESTEROLAEMIA 8 0.0227
54 ONYCHOMADESIS 95 0.0226
55 BILE ACIDS INCREASED 4 0.0226
56 FLAT ANTERIOR CHAMBER OF EYE 4 0.0223
57 RETINAL OCCLUSIVE VASCULITIS 5 0.0223
58 NAIL BED INFLAMMATION 7 0.0219
59 RHEUMATIC FEVER 97 0.0217
60 RETINAL PIGMENT EPITHELIAL TEAR 15 0.0216
61 ANTERIOR CHAMBER FLARE 5 0.0215
62 DISORDER OF ORBIT 3 0.0208
63 VITREOUS DISORDER 10 0.0207
64 MACULAR SCAR 4 0.0206
65 SUBRETINAL FIBROSIS 4 0.0205
66 CATARACT CORTICAL 3 0.0201
67 LIP ULCERATION 23 0.0197
68 VISUAL ACUITY REDUCED TRANSIENTLY 6 0.0195
69 CORNEAL DECOMPENSATION 3 0.0186
70 EYE OPERATION COMPLICATION 3 0.0183
71 CORNEAL ABRASION 25 0.0182
72 ONYCHOMYCOSIS 78 0.0178
73 DIABETIC RETINAL OEDEMA 9 0.0177
74 MACULAR FIBROSIS 11 0.0162
75 POSTERIOR CAPSULE OPACIFICATION 5 0.0146
76 FACET JOINT SYNDROME 47 0.0144
77 EPIRETINAL MEMBRANE 4 0.0144
78 HYPOPARATHYROIDISM 11 0.0143
79 HYPOTONY OF EYE 6 0.0143
80 VITREOUS OPACITIES 12 0.0142
81 INTRAOCULAR LENS IMPLANT 7 0.0141
82 CORNEAL INFECTION 3 0.0138
83 CHRONIC HEPATITIS 11 0.0136
84 HYPHAEMA 7 0.0134
85 SKIN CANDIDA 7 0.0134
86 VITREOUS DETACHMENT 29 0.0134
87 CORNEAL OPACITY 18 0.0132
88 METAMORPHOPSIA 24 0.0130
89 CAUSTIC INJURY 4 0.0128
90 EYE INFECTION BACTERIAL 7 0.0125
91 VITREOUS HAEMORRHAGE 34 0.0123
92 RETINAL EXUDATES 11 0.0118
93 CHOROIDAL NEOVASCULARISATION 10 0.0117
94 DENTURE WEARER 3 0.0116
95 C-REACTIVE PROTEIN ABNORMAL 73 0.0114
96 ENTEROCUTANEOUS FISTULA 10 0.0113
97 PERIPHERAL VENOUS DISEASE 46 0.0113
98 MATERNAL EXPOSURE DURING DELIVERY 11 0.0111
99 OCULAR TOXICITY 12 0.0109
100 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 6 0.0107
101 PEMPHIGUS 132 0.0105
102 BURNS FIRST DEGREE 3 0.0105
103 EYE INFECTION STAPHYLOCOCCAL 3 0.0104
104 RETINAL INJURY 8 0.0104
105 NASAL MUCOSAL DISORDER 6 0.0103
106 VASOCONSTRICTION 9 0.0103
107 ECTHYMA 4 0.0100
108 RETINAL OEDEMA 19 0.0099
109 BLEPHAROSPASM 62 0.0098
110 EYE ABSCESS 3 0.0098
111 OCULAR HYPERTENSION 18 0.0093
112 PRODUCT CONTAMINATION MICROBIAL 11 0.0092
113 LENTICULAR OPACITIES 4 0.0092
114 DUODENAL ULCER PERFORATION 67 0.0090
115 EXOPHTHALMOS 19 0.0088
116 LUPUS VULGARIS 11 0.0087
117 ENDOCRINE DISORDER 11 0.0086
118 EYE OEDEMA 21 0.0086
119 RETINAL VASCULAR DISORDER 5 0.0085
120 TONGUE ERYTHEMA 7 0.0085
121 BREAST CANCER STAGE III 55 0.0085
122 CYSTOID MACULAR OEDEMA 16 0.0085
123 KERATIC PRECIPITATES 4 0.0084
124 EYE SYMPTOM 3 0.0084
125 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 60 0.0084
126 PERICARDITIS 140 0.0083
127 RETINAL ISCHAEMIA 5 0.0082
128 OPEN ANGLE GLAUCOMA 5 0.0081
129 POST PROCEDURAL DISCOMFORT 17 0.0081
130 IRIS ADHESIONS 4 0.0078
131 GLARE 4 0.0078
132 OLIGURIA 48 0.0077
133 MACULAR OEDEMA 43 0.0077
134 VITREOUS FLOATERS 75 0.0076
135 FOLLICULITIS 79 0.0075
136 DEEP VEIN THROMBOSIS POSTOPERATIVE 15 0.0075
137 RETINAL DISORDER 19 0.0073
138 EYE INFLAMMATION 69 0.0072
139 PRESBYOPIA 4 0.0072
140 CULTURE POSITIVE 6 0.0072
141 OVERLAP SYNDROME 5 0.0071
142 TWIN PREGNANCY 6 0.0071
143 IRIDOCYCLITIS 22 0.0070
144 RETINITIS 12 0.0069
145 CHEMICAL BURN 8 0.0069
146 CELLULITIS ORBITAL 4 0.0069
147 BANKRUPTCY 3 0.0067
148 BRAIN STEM SYNDROME 5 0.0067
149 SYNOVITIS 120 0.0066
150 ALLERGY TEST POSITIVE 3 0.0066
151 RETINAL HAEMORRHAGE 47 0.0066
152 CATARACT SUBCAPSULAR 4 0.0066
153 MUSCLE INJURY 54 0.0065
154 CAUDA EQUINA SYNDROME 5 0.0065
155 STRESS URINARY INCONTINENCE 7 0.0065
156 SKIN TEST POSITIVE 6 0.0064
157 HYPERCHOLESTEROLAEMIA 60 0.0062
158 LIP DRY 55 0.0060
159 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 4 0.0060
160 STREPTOCOCCAL SEPSIS 7 0.0059
161 ARACHNOIDITIS 4 0.0058
162 FINGER DEFORMITY 28 0.0058
163 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 8 0.0057
164 CORNEAL EROSION 3 0.0056
165 AMNIOTIC CAVITY INFECTION 4 0.0055
166 SUBRETINAL FLUID 6 0.0055
167 FOREIGN BODY SENSATION IN EYES 35 0.0055
168 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 5 0.0054
169 CHOROIDAL DETACHMENT 3 0.0054
170 RETINAL DEGENERATION 7 0.0054
171 CONJUNCTIVAL HYPERAEMIA 19 0.0053
172 INTRAOCULAR PRESSURE INCREASED 67 0.0052
173 HELICOBACTER INFECTION 53 0.0052
174 NAIL DISORDER 45 0.0051
175 PSEUDOMONAL SEPSIS 9 0.0051
176 VITILIGO 12 0.0051
177 EMBOLIA CUTIS MEDICAMENTOSA 4 0.0050
178 BURSITIS 61 0.0050
179 LIVE BIRTH 42 0.0050
180 WOUND 139 0.0050
181 VISUAL ACUITY REDUCED 165 0.0050
182 GIANT CELL ARTERITIS 4 0.0048
183 HAND DEFORMITY 63 0.0048
184 CORNEAL PERFORATION 3 0.0048
185 CONJUNCTIVAL HAEMORRHAGE 18 0.0047
186 WOUND INFECTION 51 0.0047
187 CHORIORETINITIS 3 0.0047
188 JOINT RANGE OF MOTION DECREASED 62 0.0046
189 UTERINE PROLAPSE 5 0.0046
190 TONSILLITIS 24 0.0046
191 PILOERECTION 5 0.0046
192 DRY AGE-RELATED MACULAR DEGENERATION 5 0.0045
193 BLEPHARITIS 18 0.0045
194 DISLOCATION OF VERTEBRA 10 0.0044
195 CERUMEN IMPACTION 4 0.0044
196 INFUSION SITE REACTION 13 0.0043
197 PUPILLARY REFLEX IMPAIRED 8 0.0043
198 DERMATITIS EXFOLIATIVE GENERALISED 15 0.0043
199 CARDIOVASCULAR INSUFFICIENCY 7 0.0043
200 FUSARIUM INFECTION 3 0.0043
201 PORPHYRIA ACUTE 6 0.0042
202 PCO2 DECREASED 4 0.0041
203 EPIDERMAL NECROSIS 4 0.0041
204 CORNEAL DISORDER 9 0.0041
205 TYPE 2 DIABETES MELLITUS 137 0.0041
206 BLINDNESS UNILATERAL 57 0.0040
207 GRIP STRENGTH DECREASED 35 0.0040
208 CHLAMYDIAL INFECTION 3 0.0040
209 MACULOPATHY 14 0.0039
210 MACULAR HOLE 5 0.0037
211 AMAUROSIS FUGAX 4 0.0037
212 C-REACTIVE PROTEIN INCREASED 135 0.0037
213 ULCERATIVE KERATITIS 10 0.0036
214 RETINAL TEAR 9 0.0036
215 STAPHYLOCOCCAL SEPSIS 18 0.0036
216 KERATITIS 11 0.0036
217 SYSTEMIC LUPUS ERYTHEMATOSUS 128 0.0036
218 GLOSSODYNIA 80 0.0036
219 EYELID OEDEMA 41 0.0035
220 EYE PAIN 199 0.0035
221 FIBROMYALGIA 84 0.0035
222 DERMATITIS BULLOUS 25 0.0035
223 MULTIPLE USE OF SINGLE-USE PRODUCT 19 0.0034
224 CONJUNCTIVITIS ALLERGIC 5 0.0034
225 RETINAL VASCULITIS 4 0.0034
226 PSORIATIC ARTHROPATHY 136 0.0033
227 CATHETER MANAGEMENT 3 0.0033
228 STAPHYLOCOCCUS TEST POSITIVE 7 0.0033
229 PREMATURE RUPTURE OF MEMBRANES 8 0.0033
230 TOXIC SKIN ERUPTION 33 0.0033
231 ORAL MUCOSAL ERUPTION 5 0.0033
232 RETINAL ARTERY OCCLUSION 8 0.0032
233 PHOTOPSIA 20 0.0032
234 COR PULMONALE 3 0.0031
235 ANGLE CLOSURE GLAUCOMA 8 0.0031
236 NORMAL NEWBORN 17 0.0031
237 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 20 0.0031
238 PSYCHIATRIC DECOMPENSATION 6 0.0031
239 PURULENT DISCHARGE 13 0.0030
240 BENIGN BREAST NEOPLASM 3 0.0029
241 OSTEOLYSIS 6 0.0029
242 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 6 0.0029
243 OCULAR DISCOMFORT 32 0.0028
244 CARPAL TUNNEL DECOMPRESSION 3 0.0028
245 BURNS THIRD DEGREE 3 0.0028
246 RETINAL DETACHMENT 26 0.0028
247 OBESITY 45 0.0028
248 PROCEDURAL HAEMORRHAGE 11 0.0028
249 DERMATITIS CONTACT 32 0.0028
250 UVEITIS 38 0.0028
251 X-RAY ABNORMAL 5 0.0028
252 ANAPHYLACTIC SHOCK 72 0.0028
253 CONTRAINDICATED PRODUCT ADMINISTERED 84 0.0028
254 EPILEPSY 84 0.0027
255 PRODUCT LABEL CONFUSION 16 0.0027
256 PARONYCHIA 12 0.0027
257 NORMOCYTIC ANAEMIA 4 0.0027
258 LIVER INJURY 66 0.0027
259 CATHETER SITE DISCHARGE 3 0.0027
260 CONJUNCTIVITIS 49 0.0026
261 ASTIGMATISM 4 0.0026
262 TASTE DISORDER 53 0.0026
263 POST PROCEDURAL COMPLICATION 49 0.0025
264 HYPERAEMIA 5 0.0025
265 IRRITABLE BOWEL SYNDROME 54 0.0025
266 SWOLLEN JOINT COUNT INCREASED 8 0.0025
267 GENITAL HAEMORRHAGE 32 0.0025
268 RASH VESICULAR 12 0.0025
269 DYSFUNCTIONAL UTERINE BLEEDING 3 0.0025
270 EYELID PAIN 5 0.0025
271 ANAPHYLACTOID REACTION 10 0.0024
272 PENIS DISORDER 6 0.0024
273 IMPAIRED SELF-CARE 5 0.0024
274 CHRONIC SINUSITIS 9 0.0024
275 STRIDOR 7 0.0024
276 IMPAIRED HEALING 78 0.0024
277 CHEMICAL BURN OF SKIN 6 0.0024
278 ULCER HAEMORRHAGE 16 0.0024
279 DIABETIC RETINOPATHY 8 0.0024
280 ADNEXA UTERI PAIN 3 0.0023
281 CATHETER SITE ERYTHEMA 5 0.0023
282 BLOOD CHLORIDE DECREASED 6 0.0023
283 HYPOALBUMINAEMIA 18 0.0023
284 CATHETER SITE PAIN 6 0.0023
285 PUPIL FIXED 4 0.0023
286 ORAL INFECTION 9 0.0023
287 HERPES OPHTHALMIC 3 0.0023
288 ANGIONEUROTIC OEDEMA 6 0.0022
289 ANAESTHETIC COMPLICATION 6 0.0022
290 BACK INJURY 24 0.0022
291 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 17 0.0022
292 BLINDNESS TRANSIENT 16 0.0022
293 BLINDNESS 86 0.0021
294 EYELID IRRITATION 5 0.0020
295 NECROTISING FASCIITIS 7 0.0020
296 VASODILATATION 5 0.0020
297 INFLAMMATION 102 0.0020
298 EYE INJURY 6 0.0020
299 IRITIS 6 0.0020
300 EYE HAEMORRHAGE 26 0.0019
301 MOUTH ULCERATION 41 0.0019
302 EYE ALLERGY 3 0.0019
303 BACTERIAL VAGINOSIS 3 0.0019
304 PERSONALITY DISORDER 5 0.0019
305 EYE IRRITATION 109 0.0019
306 FEBRILE BONE MARROW APLASIA 8 0.0019
307 INFUSION RELATED REACTION 124 0.0019
308 POOR QUALITY DRUG ADMINISTERED 12 0.0019
309 TOXIC EPIDERMAL NECROLYSIS 28 0.0018
310 LYMPHOPENIA 26 0.0018
311 EYE DISCHARGE 19 0.0018
312 ASTHENOPIA 10 0.0018
313 BACTERIAL TEST POSITIVE 4 0.0018
314 WOUND SECRETION 7 0.0018
315 THERAPEUTIC PRODUCT EFFECT DECREASED 80 0.0018
316 URINARY TRACT DISORDER 8 0.0018
317 CHRONIC GASTRITIS 4 0.0018
318 NIGHT SWEATS 57 0.0018
319 ENTERITIS INFECTIOUS 3 0.0018
320 PATHOGEN RESISTANCE 16 0.0018
321 LACRIMATION INCREASED 53 0.0018
322 PUSTULAR PSORIASIS 6 0.0017
323 ADVERSE REACTION 23 0.0017
324 RHEUMATOID FACTOR POSITIVE 10 0.0017
325 BLISTER 97 0.0017
326 BURNS SECOND DEGREE 3 0.0017
327 TYPE I HYPERSENSITIVITY 6 0.0017
328 HYPERURICAEMIA 7 0.0017
329 PHOTOPHOBIA 32 0.0017
330 OCULAR HYPERAEMIA 80 0.0017
331 MYOSITIS 15 0.0017
332 PULSE ABNORMAL 4 0.0017
333 ABNORMAL SENSATION IN EYE 7 0.0016
334 STOMATITIS 98 0.0016
335 ANAPHYLACTIC REACTION 89 0.0016
336 SKIN INFECTION 18 0.0016
337 CATHETER SITE HAEMORRHAGE 4 0.0016
338 DERMATITIS EXFOLIATIVE 8 0.0016
339 GAIT INABILITY 53 0.0016
340 IRON DEFICIENCY 7 0.0016
341 VASCULAR DEVICE INFECTION 7 0.0015
342 CANDIDA INFECTION 26 0.0015
343 CONCOMITANT DISEASE PROGRESSION 3 0.0015
344 OSTEOARTHRITIS 65 0.0015
345 DEAFNESS NEUROSENSORY 5 0.0015
346 SUDDEN DEATH 16 0.0015
347 PROCEDURAL PAIN 41 0.0015
348 SWELLING 137 0.0015
349 KIDNEY TRANSPLANT REJECTION 7 0.0015
350 WOUND COMPLICATION 5 0.0015
351 ORAL CANDIDIASIS 19 0.0014
352 UNDERDOSE 105 0.0014
353 STREPTOCOCCAL INFECTION 8 0.0014
354 FOETAL DISTRESS SYNDROME 3 0.0014
355 BONE EROSION 5 0.0014
356 TONGUE DISCOMFORT 6 0.0014
357 EMBEDDED DEVICE 14 0.0014
358 UTERINE HAEMORRHAGE 6 0.0014
359 GENERALISED ERYTHEMA 8 0.0014
360 DRUG-INDUCED LIVER INJURY 44 0.0014
361 BLOOD CHOLESTEROL INCREASED 65 0.0014
362 DISCOMFORT 85 0.0014
363 LOWER RESPIRATORY TRACT INFECTION 63 0.0014
364 VAGINAL DISCHARGE 14 0.0014
365 ILL-DEFINED DISORDER 84 0.0014
366 SLEEP DISORDER 97 0.0014
367 METASTASES TO LYMPH NODES 9 0.0013
368 PAPILLOEDEMA 6 0.0013
369 COELIAC DISEASE 13 0.0013
370 DYSCHEZIA 4 0.0013
371 MEDICAL DEVICE DISCOMFORT 4 0.0013
372 INJECTION SITE REACTION 90 0.0013
373 RASH MACULO-PAPULAR 29 0.0013
374 ERYTHEMA OF EYELID 7 0.0013
375 HAEMATURIA 44 0.0013
376 RHEUMATOID ARTHRITIS 145 0.0013
377 SWELLING OF EYELID 8 0.0013
378 LUNG DISORDER 62 0.0013
379 SCIATICA 20 0.0013
380 ENTEROCOCCAL INFECTION 6 0.0012
381 RASH PUSTULAR 9 0.0012
382 DEVICE RELATED INFECTION 19 0.0012
383 GLOMERULONEPHRITIS 3 0.0012
384 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 87 0.0012
385 DERMAL CYST 3 0.0012
386 LUPUS-LIKE SYNDROME 11 0.0012
387 HYPERPARATHYROIDISM SECONDARY 3 0.0012
388 VISION BLURRED 164 0.0012
389 POSTOPERATIVE WOUND INFECTION 8 0.0012
390 LIP OEDEMA 5 0.0012
391 RED BLOOD CELL SEDIMENTATION RATE INCREASED 13 0.0012
392 CANCER PAIN 3 0.0012
393 ABSCESS LIMB 5 0.0012
394 MACULAR DEGENERATION 14 0.0012
395 TREATMENT FAILURE 97 0.0012
396 GASTROENTERITIS 17 0.0012
397 VARICOSE VEIN 6 0.0012
398 VISUAL IMPAIRMENT 143 0.0012
399 INTENTIONAL PRODUCT USE ISSUE 101 0.0012
400 COMPARTMENT SYNDROME 3 0.0011
401 WHEEZING 68 0.0011
402 EOSINOPHILIA 20 0.0011
403 MELANOCYTIC NAEVUS 5 0.0011
404 APPLICATION SITE REACTION 8 0.0011
405 RENAL FAILURE ACUTE 48 0.0011
406 THERMAL BURN 8 0.0011
407 ARTHROPATHY 62 0.0011
408 VISUAL FIELD DEFECT 8 0.0011
409 SPONDYLITIS 4 0.0011
410 UTERINE LEIOMYOMA 8 0.0011
411 GASTROOESOPHAGEAL REFLUX DISEASE 87 0.0011
412 ROSACEA 5 0.0011
413 ERYTHEMA MULTIFORME 10 0.0011
414 ACUTE PULMONARY OEDEMA 6 0.0011
415 SKIN REACTION 15 0.0011
416 BREAST CANCER STAGE IV 3 0.0011
417 CATHETER SITE INFECTION 4 0.0011
418 SUBCUTANEOUS ABSCESS 5 0.0010
419 FINE MOTOR SKILL DYSFUNCTION 3 0.0010
420 MATERNAL EXPOSURE DURING PREGNANCY 92 0.0010
421 STAPHYLOCOCCAL INFECTION 34 0.0010
422 AUTOIMMUNE DISORDER 10 0.0010
423 LIVER FUNCTION TEST INCREASED 22 0.0010
424 SWOLLEN TONGUE 32 0.0010
425 CATARACT 61 0.0010
426 EYE SWELLING 38 0.0010
427 OEDEMA 55 0.0010
428 BLOOD CULTURE POSITIVE 3 0.0010
429 BONE MARROW DISORDER 3 0.0010
430 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17 0.0010
431 PELVIC PAIN 18 0.0010
432 ABDOMINAL PAIN LOWER 25 0.0010
433 POST PROCEDURAL INFECTION 8 0.0010
434 LARYNGEAL OEDEMA 6 0.0010
435 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
436 SEPTIC SHOCK 42 0.0010
437 SKIN NECROSIS 5 0.0010
438 LYMPHOCYTE COUNT DECREASED 17 0.0010
439 COMPLICATION OF DEVICE INSERTION 19 0.0010
440 EYE PRURITUS 32 0.0010
441 HYPOCALCAEMIA 18 0.0010
442 BLOOD LACTIC ACID INCREASED 5 0.0009
443 SKIN LESION 26 0.0009
444 CONFUSIONAL STATE 152 0.0009
445 PULMONARY FIBROSIS 18 0.0009
446 DRUG INTOLERANCE 90 0.0009
447 ANAL ABSCESS 5 0.0009
448 GINGIVITIS 5 0.0009
449 HORDEOLUM 4 0.0009
450 DRY MOUTH 75 0.0009
451 CHEILITIS 5 0.0009
452 RENAL TUBULAR NECROSIS 9 0.0009
453 HYPOGAMMAGLOBULINAEMIA 6 0.0009
454 APHTHOUS ULCER 7 0.0009
455 RHINITIS ALLERGIC 4 0.0009
456 EYE INFECTION 10 0.0009
457 HYPERSENSITIVITY 164 0.0009
458 LOW BIRTH WEIGHT BABY 7 0.0009
459 GRANULOCYTOPENIA 5 0.0009
460 EXOSTOSIS 8 0.0009
461 DERMATITIS ALLERGIC 11 0.0009
462 ISCHAEMIA 4 0.0009
463 URTICARIA 145 0.0009
464 LOCALISED OEDEMA 4 0.0009
465 NEPHROGENIC ANAEMIA 4 0.0009
466 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
467 FIBRIN D DIMER INCREASED 3 0.0008
468 BLOOD PRESSURE INADEQUATELY CONTROLLED 5 0.0008
469 GANGRENE 5 0.0008
470 HYPOXIA 29 0.0008
471 MUSCULOSKELETAL PAIN 43 0.0008
472 GENERALISED OEDEMA 10 0.0008
473 HYPOKALAEMIA 37 0.0008
474 OVARIAN CYST 8 0.0008
475 PATHOLOGICAL FRACTURE 4 0.0008
476 DYSLIPIDAEMIA 4 0.0008
477 PROCEDURAL COMPLICATION 6 0.0008
478 ASCITES 23 0.0008
479 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
480 FACE OEDEMA 13 0.0008
481 BRONCHOSPASM 11 0.0008
482 JOINT SWELLING 93 0.0008
483 MIGRAINE 73 0.0008
484 ABDOMINAL DISCOMFORT 128 0.0008
485 CANDIDIASIS 3 0.0007
486 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 19 0.0007
487 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
488 ARTHRITIS BACTERIAL 3 0.0007
489 EYE MOVEMENT DISORDER 5 0.0007
490 ECCHYMOSIS 5 0.0007
491 LOWER LIMB FRACTURE 14 0.0007
492 SPINAL COMPRESSION FRACTURE 6 0.0007
493 HYPERKERATOSIS 4 0.0007
494 DEFAECATION URGENCY 5 0.0007
495 RASH ERYTHEMATOUS 34 0.0007
496 PRODUCT USE IN UNAPPROVED INDICATION 176 0.0007
497 SKIN TOXICITY 4 0.0007
498 PREMATURE LABOUR 4 0.0007
499 SINUS TACHYCARDIA 10 0.0007
500 GENERAL PHYSICAL HEALTH DETERIORATION 81 0.0007
501 PSEUDOMONAS INFECTION 6 0.0007
502 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
503 BACTERIAL INFECTION 13 0.0007
504 HEPATIC CIRRHOSIS 13 0.0007
505 URINE OUTPUT DECREASED 6 0.0007
506 HYPERTRIGLYCERIDAEMIA 4 0.0007
507 ORAL DISORDER 5 0.0007
508 MELAENA 15 0.0007
509 GINGIVAL SWELLING 3 0.0007
510 STEVENS-JOHNSON SYNDROME 15 0.0007
511 CATARACT OPERATION 4 0.0007
512 ODYNOPHAGIA 4 0.0007
513 DERMATITIS 14 0.0007
514 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
515 RASH 287 0.0007
516 DYSPAREUNIA 3 0.0007
517 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
518 FEBRILE NEUTROPENIA 43 0.0006
519 BLOOD SODIUM DECREASED 12 0.0006
520 DEVICE DEPLOYMENT ISSUE 8 0.0006
521 INJURY 44 0.0006
522 FAECAL INCONTINENCE 3 0.0006
523 PARAESTHESIA ORAL 9 0.0006
524 FISTULA 7 0.0006
525 RHINITIS 5 0.0006
526 POLYURIA 5 0.0006
527 APPLICATION SITE BURN 3 0.0006
528 WALKING AID USER 4 0.0006
529 PRODUCT USE ISSUE 114 0.0006
530 ANEURYSM 3 0.0006
531 HEPATIC ENZYME ABNORMAL 3 0.0006
532 DEVICE DISLOCATION 26 0.0006
533 HYPOAESTHESIA ORAL 9 0.0006
534 ERYSIPELAS 3 0.0006
535 UTERINE PERFORATION 5 0.0006
536 RASH GENERALISED 15 0.0006
537 DIPLOPIA 15 0.0006
538 NOCTURIA 7 0.0006
539 MASS 8 0.0006
540 RASH MACULAR 20 0.0006
541 GLAUCOMA 11 0.0006
542 MUSCULOSKELETAL STIFFNESS 50 0.0006
543 OFF LABEL USE 495 0.0006
544 NEUTROPHIL COUNT DECREASED 23 0.0006
545 ABSCESS 9 0.0006
546 EXPOSURE DURING PREGNANCY 35 0.0006
547 WRONG DRUG ADMINISTERED 5 0.0006
548 MENORRHAGIA 11 0.0006
549 BRUXISM 3 0.0006
550 CELLULITIS 28 0.0006
551 HYPOAESTHESIA 83 0.0006
552 BRAIN OEDEMA 7 0.0006
553 HYDROCEPHALUS 3 0.0006
554 SEPSIS 61 0.0005
555 MYDRIASIS 7 0.0005
556 ALOPECIA 107 0.0005
557 DEAFNESS UNILATERAL 3 0.0005
558 RESPIRATORY DISTRESS 15 0.0005
559 HYPERTENSION 115 0.0005
560 GASTRIC ULCER HAEMORRHAGE 3 0.0005
561 NECK PAIN 30 0.0005
562 APPENDICITIS 5 0.0005
563 HYDRONEPHROSIS 4 0.0005
564 CIRCULATORY COLLAPSE 9 0.0005
565 GASTROINTESTINAL DISORDER 47 0.0005
566 RECALLED PRODUCT ADMINISTERED 5 0.0005
567 ANGIOEDEMA 23 0.0005
568 ATELECTASIS 5 0.0005
569 PRESCRIBED OVERDOSE 10 0.0005
570 CONGENITAL ANOMALY 4 0.0005
571 LUNG INFECTION 8 0.0005
572 DEVICE USE ISSUE 9 0.0005
573 EAR PAIN 10 0.0005
574 HEPATIC ENZYME INCREASED 35 0.0005
575 HAEMORRHAGIC STROKE 4 0.0005
576 MEMORY IMPAIRMENT 70 0.0005
577 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
578 DRUG RESISTANCE 13 0.0005
579 BACTERAEMIA 6 0.0005
580 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
581 RESPIRATORY DISORDER 15 0.0005
582 PRESCRIBED UNDERDOSE 10 0.0005
583 DYSPEPSIA 49 0.0005
584 GAMMA-GLUTAMYLTRANSFERASE INCREASED 11 0.0005
585 SCHIZOPHRENIA 6 0.0005
586 PRODUCT QUALITY ISSUE 67 0.0005
587 DERMATITIS ACNEIFORM 3 0.0005
588 DECUBITUS ULCER 4 0.0005
589 NEUTROPHIL COUNT INCREASED 5 0.0005
590 METASTASES TO BONE 8 0.0005
591 HYPERAESTHESIA 4 0.0005
592 OSTEONECROSIS OF JAW 12 0.0005
593 PHARYNGITIS 6 0.0005
594 ILEUS 6 0.0005
595 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
596 DRY EYE 24 0.0005
597 NERVOUS SYSTEM DISORDER 15 0.0005
598 SHOCK 11 0.0005
599 NASOPHARYNGITIS 88 0.0005
600 MOBILITY DECREASED 34 0.0005
601 JOINT DISLOCATION 5 0.0005
602 HEPATITIS 12 0.0005
603 SINUSITIS 48 0.0005
604 THERAPY NON-RESPONDER 21 0.0005
605 ANOREXIA 6 0.0005
606 ANURIA 4 0.0005
607 SKIN ULCER 12 0.0005
608 DEPRESSION 105 0.0005
609 PLATELET COUNT INCREASED 6 0.0005
610 LEUKOPENIA 23 0.0005
611 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
612 ASPERGILLUS INFECTION 3 0.0005
613 EYE DISORDER 15 0.0005
614 CARDIO-RESPIRATORY ARREST 19 0.0005
615 LUNG INFILTRATION 4 0.0005
616 PRESYNCOPE 11 0.0005
617 FOOT DEFORMITY 5 0.0005
618 INTESTINAL OBSTRUCTION 17 0.0005
619 BLOOD BILIRUBIN INCREASED 12 0.0004
620 OSTEOMYELITIS 8 0.0004
621 ACUTE MYOCARDIAL INFARCTION 13 0.0004
622 CYSTITIS 14 0.0004
623 ECZEMA 23 0.0004
624 MYOCARDIAL ISCHAEMIA 5 0.0004
625 END STAGE RENAL DISEASE 8 0.0004
626 SKIN EXFOLIATION 37 0.0004
627 VAGINAL HAEMORRHAGE 19 0.0004
628 PERIPHERAL SWELLING 67 0.0004
629 ERYTHEMA 89 0.0004
630 DELIRIUM 15 0.0004
631 DEVICE EXPULSION 28 0.0004
632 POST PROCEDURAL HAEMORRHAGE 5 0.0004
633 VASCULITIS 5 0.0004
634 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
635 PHARMACEUTICAL PRODUCT COMPLAINT 11 0.0004
636 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
637 DIVERTICULUM 3 0.0004
638 FEAR OF INJECTION 3 0.0004
639 JOINT STIFFNESS 11 0.0004
640 HYPERLIPIDAEMIA 5 0.0004
641 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
642 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
643 MEDICATION ERROR 23 0.0004
644 WRONG TECHNIQUE IN DRUG USAGE PROCESS 15 0.0004
645 ORAL HERPES 8 0.0004
646 SKIN FISSURES 8 0.0004
647 APPLICATION SITE PAIN 9 0.0004
648 ABDOMINAL PAIN UPPER 84 0.0004
649 HYPOTHYROIDISM 13 0.0004
650 BODY TEMPERATURE DECREASED 4 0.0004
651 ABDOMINAL PAIN 94 0.0004
652 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
653 HEPATIC FUNCTION ABNORMAL 15 0.0004
654 RASH PAPULAR 9 0.0004
655 CONDITION AGGRAVATED 121 0.0004
656 PYREXIA 137 0.0004
657 HEAD DISCOMFORT 7 0.0004
658 DRUG ERUPTION 7 0.0004
659 HAEMODYNAMIC INSTABILITY 3 0.0004
660 BONE MARROW FAILURE 8 0.0004
661 DECREASED APPETITE 91 0.0004
662 VIRAL INFECTION 13 0.0004
663 HYPONATRAEMIA 22 0.0004
664 URINARY RETENTION 13 0.0004
665 ROTATOR CUFF SYNDROME 5 0.0004
666 OSTEOPOROSIS 16 0.0004
667 HAEMOLYSIS 3 0.0004
668 HYPERBILIRUBINAEMIA 4 0.0004
669 HYPERGLYCAEMIA 14 0.0004
670 NODULE 5 0.0004
671 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
672 INJECTION SITE DISCOMFORT 4 0.0004
673 PLEURAL EFFUSION 23 0.0004
674 PLATELET COUNT DECREASED 40 0.0004
675 RASH PRURITIC 20 0.0004
676 HYPOTENSION 74 0.0004
677 HICCUPS 3 0.0004
678 MUSCLE SPASMS 67 0.0004
679 PAIN 224 0.0004
680 ABDOMINAL DISTENSION 38 0.0004
681 PHOTOSENSITIVITY REACTION 6 0.0004
682 ANAEMIA 69 0.0004
683 BREAST CANCER STAGE II 3 0.0004
684 TACHYCARDIA 32 0.0004
685 CARPAL TUNNEL SYNDROME 5 0.0004
686 RESPIRATORY FAILURE 26 0.0004
687 PANCREATITIS ACUTE 8 0.0004
688 MITRAL VALVE INCOMPETENCE 4 0.0004
689 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
690 MICTURITION URGENCY 4 0.0003
691 PREGNANCY 7 0.0003
692 IMPAIRED QUALITY OF LIFE 5 0.0003
693 MULTI-ORGAN FAILURE 6 0.0003
694 MYELODYSPLASTIC SYNDROME 5 0.0003
695 OEDEMA PERIPHERAL 42 0.0003
696 AMENORRHOEA 6 0.0003
697 PNEUMONIA 110 0.0003
698 LYMPHADENOPATHY 12 0.0003
699 PRURITUS 130 0.0003
700 LIVER DISORDER 15 0.0003
701 BLOOD CREATININE INCREASED 22 0.0003
702 PARAESTHESIA 53 0.0003
703 DISEASE RECURRENCE 16 0.0003
704 IMMUNODEFICIENCY 5 0.0003
705 HAEMOLYTIC ANAEMIA 3 0.0003
706 GASTROINTESTINAL INFECTION 3 0.0003
707 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
708 PREMATURE BABY 10 0.0003
709 LEUKOCYTOSIS 6 0.0003
710 LOCALISED INFECTION 8 0.0003
711 PALLOR 9 0.0003
712 WEIGHT INCREASED 74 0.0003
713 NO THERAPEUTIC RESPONSE 4 0.0003
714 MUSCULAR WEAKNESS 37 0.0003
715 CARDIOMEGALY 4 0.0003
716 HYPERCALCAEMIA 4 0.0003
717 VOMITING 152 0.0003
718 CYST 4 0.0003
719 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
720 ARTERIOSCLEROSIS 3 0.0003
721 BRONCHITIS 23 0.0003
722 NAUSEA 245 0.0003
723 OVERDOSE 66 0.0003
724 MUCOSAL INFLAMMATION 8 0.0003
725 TINNITUS 14 0.0003
726 HAEMATOCRIT DECREASED 6 0.0003
727 OXYGEN SATURATION DECREASED 17 0.0003
728 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
729 RESTLESSNESS 11 0.0003
730 CARDIAC FAILURE 24 0.0003
731 MENSTRUATION IRREGULAR 8 0.0003
732 BLOOD UREA INCREASED 5 0.0003
733 FREQUENT BOWEL MOVEMENTS 8 0.0003
734 EYELID PTOSIS 3 0.0003
735 DRUG EXPOSURE DURING PREGNANCY 10 0.0003
736 DRUG TOXICITY 4 0.0003
737 COLITIS 11 0.0003
738 NEURALGIA 7 0.0003
739 ORAL DISCOMFORT 4 0.0003
740 ROAD TRAFFIC ACCIDENT 12 0.0003
741 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
742 BLOOD PRESSURE DECREASED 19 0.0003
743 DYSPNOEA 161 0.0003
744 PANCREATITIS 15 0.0003
745 ASTHMA 32 0.0003
746 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
747 METABOLIC ACIDOSIS 9 0.0003
748 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
749 CONTUSION 27 0.0003
750 PNEUMONIA ASPIRATION 7 0.0003
751 RHINORRHOEA 18 0.0003
752 COMPLICATION OF DEVICE REMOVAL 5 0.0003
753 CHOLELITHIASIS 9 0.0003
754 BLOOD GLUCOSE FLUCTUATION 3 0.0003
755 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
756 ARTHRALGIA 113 0.0003
757 CARDIOMYOPATHY 4 0.0003
758 HAEMATOMA 7 0.0003
759 PANCYTOPENIA 15 0.0003
760 BRADYCARDIA 14 0.0003
761 ECONOMIC PROBLEM 4 0.0003
762 OSTEOPENIA 4 0.0003
763 EAR INFECTION 7 0.0003
764 ACUTE KIDNEY INJURY 40 0.0003
765 AMNESIA 17 0.0003
766 HIP ARTHROPLASTY 4 0.0003
767 SKIN DISCOLOURATION 12 0.0003
768 INSOMNIA 69 0.0003
769 LIMB INJURY 7 0.0003
770 ACUTE MYELOID LEUKAEMIA 4 0.0003
771 HYPERKALAEMIA 9 0.0003
772 ADVERSE DRUG REACTION 23 0.0003
773 RECTAL HAEMORRHAGE 11 0.0003
774 CHILLS 30 0.0003
775 CYANOSIS 4 0.0003
776 RESPIRATORY ARREST 7 0.0003
777 MALAISE 111 0.0003
778 DISABILITY 5 0.0003
779 FALL 84 0.0003
780 CHOLECYSTITIS 3 0.0003
781 ULCER 4 0.0003
782 PRODUCTIVE COUGH 12 0.0003
783 INTERSTITIAL LUNG DISEASE 12 0.0002
784 FEEDING DISORDER 5 0.0002
785 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
786 CARDIAC ARREST 20 0.0002
787 EPISTAXIS 18 0.0002
788 LIP SWELLING 8 0.0002
789 FUNGAL INFECTION 8 0.0002
790 SKIN DISORDER 8 0.0002
791 ADVERSE EVENT 22 0.0002
792 KNEE ARTHROPLASTY 5 0.0002
793 URINARY INCONTINENCE 7 0.0002
794 DIABETES MELLITUS 18 0.0002
795 HEMIPARESIS 4 0.0002
796 DRUG INEFFECTIVE 311 0.0002
797 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
798 INFECTION 34 0.0002
799 RETCHING 5 0.0002
800 PAIN IN EXTREMITY 69 0.0002
801 FOETAL EXPOSURE DURING PREGNANCY 19 0.0002
802 SCAR 4 0.0002
803 HYPOACUSIS 10 0.0002
804 CHEST PAIN 43 0.0002
805 ORTHOSTATIC HYPOTENSION 4 0.0002
806 DEAFNESS 6 0.0002
807 LOCAL SWELLING 4 0.0002
808 APPLICATION SITE ERYTHEMA 6 0.0002
809 METASTASES TO LIVER 4 0.0002
810 DYSMENORRHOEA 3 0.0002
811 DYSPHONIA 13 0.0002
812 PNEUMONITIS 6 0.0002
813 HEADACHE 138 0.0002
814 CONSTIPATION 48 0.0002
815 DIARRHOEA 142 0.0002
816 DYSURIA 8 0.0002
817 DIZZINESS 107 0.0002
818 DEVICE OCCLUSION 3 0.0002
819 HALLUCINATION 16 0.0002
820 RENAL FAILURE 28 0.0002
821 DYSPHAGIA 20 0.0002
822 CHRONIC KIDNEY DISEASE 16 0.0002
823 PROTEINURIA 4 0.0002
824 MUSCULOSKELETAL DISORDER 4 0.0002
825 HERPES ZOSTER 12 0.0002
826 BLOOD PRESSURE FLUCTUATION 5 0.0002
827 ACUTE RESPIRATORY FAILURE 4 0.0002
828 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
829 ANOSMIA 3 0.0002
830 HYPERTHYROIDISM 3 0.0002
831 ASTHENIA 76 0.0002
832 URINARY TRACT INFECTION 34 0.0002
833 HEPATIC FAILURE 6 0.0002
834 VERTIGO 12 0.0002
835 THROMBOCYTOPENIA 22 0.0002
836 SKIN IRRITATION 9 0.0002
837 FEELING HOT 12 0.0002
838 CEREBROVASCULAR ACCIDENT 33 0.0002
839 OROPHARYNGEAL PAIN 18 0.0002
840 PERITONITIS 4 0.0002
841 SEDATION 5 0.0002
842 SYNCOPE 19 0.0002
843 EATING DISORDER 4 0.0002
844 CARDIAC FAILURE CONGESTIVE 15 0.0002
845 JAUNDICE 5 0.0002
846 BLOOD POTASSIUM INCREASED 3 0.0002
847 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
848 GAIT DISTURBANCE 35 0.0002
849 FATIGUE 142 0.0002
850 CYTOMEGALOVIRUS INFECTION 3 0.0002
851 COAGULOPATHY 3 0.0002
852 MENTAL STATUS CHANGES 5 0.0002
853 DEVICE ISSUE 16 0.0002
854 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
855 NEUTROPENIA 24 0.0002
856 BACK PAIN 41 0.0002
857 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
858 HAEMOGLOBIN DECREASED 18 0.0002
859 RED BLOOD CELL COUNT DECREASED 5 0.0002
860 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
861 LOSS OF CONSCIOUSNESS 22 0.0002
862 COUGH 48 0.0002
863 NASAL CONGESTION 10 0.0002
864 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
865 PSYCHOTIC DISORDER 5 0.0002
866 COMA 8 0.0002
867 GOUT 3 0.0002
868 APHASIA 5 0.0002
869 ARTHRITIS 13 0.0002
870 CRYING 6 0.0002
871 BONE DISORDER 3 0.0002
872 TREATMENT NONCOMPLIANCE 9 0.0002
873 CEREBRAL INFARCTION 4 0.0002
874 BLOOD PRESSURE INCREASED 25 0.0002
875 AGRANULOCYTOSIS 3 0.0002
876 HEPATIC STEATOSIS 3 0.0002
877 AGEUSIA 4 0.0002
878 HAEMATEMESIS 4 0.0002
879 FEELING JITTERY 3 0.0002
880 BURNING SENSATION 11 0.0002
881 THROAT IRRITATION 7 0.0002
882 HIP FRACTURE 5 0.0002
883 HAEMORRHOIDS 3 0.0002
884 SWELLING FACE 10 0.0002
885 HAEMORRHAGE 16 0.0002
886 OSTEONECROSIS 5 0.0002
887 GASTRITIS 4 0.0002
888 DEPRESSED MOOD 8 0.0002
889 DEVICE DIFFICULT TO USE 10 0.0002
890 BLOOD PRESSURE ABNORMAL 3 0.0002
891 WEIGHT DECREASED 42 0.0002
892 AGITATION 11 0.0001
893 THROAT TIGHTNESS 4 0.0001
894 UNEVALUABLE EVENT 11 0.0001
895 NIGHTMARE 5 0.0001
896 FEELING COLD 4 0.0001
897 BLOOD GLUCOSE INCREASED 27 0.0001
898 DEMENTIA 4 0.0001
899 HALLUCINATION, VISUAL 3 0.0001
900 PAIN IN JAW 4 0.0001
901 HYPERHIDROSIS 18 0.0001
902 ANGINA PECTORIS 4 0.0001
903 BALANCE DISORDER 12 0.0001
904 FLUID RETENTION 7 0.0001
905 LABORATORY TEST ABNORMAL 4 0.0001
906 PULMONARY OEDEMA 6 0.0001
907 ATRIAL FIBRILLATION 13 0.0001
908 CHROMATURIA 3 0.0001
909 APPLICATION SITE PRURITUS 3 0.0001
910 CORONARY ARTERY DISEASE 4 0.0001
911 HEAD INJURY 4 0.0001
912 INTENTIONAL PRODUCT MISUSE 11 0.0001
913 MYALGIA 21 0.0001
914 DEVICE BREAKAGE 5 0.0001
915 LUNG NEOPLASM MALIGNANT 5 0.0001
916 NO ADVERSE EVENT 22 0.0001
917 SEIZURE 14 0.0001
918 RHABDOMYOLYSIS 5 0.0001
919 ANXIETY 34 0.0001
920 DISEASE PROGRESSION 14 0.0001
921 CHEST DISCOMFORT 12 0.0001
922 THERAPEUTIC RESPONSE DECREASED 7 0.0001
923 SOMNOLENCE 23 0.0001
924 ANHEDONIA 3 0.0001
925 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
926 ABNORMAL DREAMS 3 0.0001
927 FLUSHING 11 0.0001
928 HAEMOPTYSIS 3 0.0001
929 RENAL IMPAIRMENT 9 0.0001
930 DYSARTHRIA 4 0.0001
931 HOSPITALISATION 16 0.0001
932 HEART RATE INCREASED 10 0.0001
933 DYSKINESIA 4 0.0001
934 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
935 FEMUR FRACTURE 3 0.0001
936 HOT FLUSH 7 0.0001
937 DRUG EFFECT DECREASED 5 0.0001
938 MENTAL DISORDER 4 0.0001
939 PSORIASIS 12 0.0001
940 FEELING ABNORMAL 22 0.0001
941 MYOCARDIAL INFARCTION 16 0.0001
942 FLATULENCE 5 0.0001
943 DEATH 74 0.0001
944 RENAL DISORDER 4 0.0001
945 CARDIAC DISORDER 8 0.0001
946 PALPITATIONS 10 0.0001
947 ARRHYTHMIA 4 0.0001
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
949 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
950 BLOOD GLUCOSE DECREASED 4 0.0001
951 IRRITABILITY 5 0.0001
952 DEHYDRATION 11 0.0001
953 ACCIDENTAL OVERDOSE 3 0.0001
954 INJECTION SITE ERYTHEMA 10 0.0001
955 DYSPNOEA EXERTIONAL 3 0.0001
956 ILLNESS 8 0.0001
957 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
958 DEEP VEIN THROMBOSIS 5 0.0001
959 NERVOUSNESS 4 0.0001
960 SPEECH DISORDER 4 0.0001
961 DISORIENTATION 3 0.0001
962 EMOTIONAL DISTRESS 9 0.0001
963 DISTURBANCE IN ATTENTION 4 0.0001
964 INFLUENZA 8 0.0001
965 DEVICE LEAKAGE 3 0.0001
966 SURGERY 4 0.0001
967 DRY SKIN 9 0.0001
968 COLITIS ULCERATIVE 3 0.0001
969 ACNE 5 0.0001
970 SUICIDAL IDEATION 6 0.0001
971 TOXICITY TO VARIOUS AGENTS 11 0.0001
972 COGNITIVE DISORDER 3 0.0001
973 PROSTATE CANCER 5 0.0001
974 INJECTION SITE PAIN 19 0.0001
975 PRODUCT DOSE OMISSION ISSUE 18 0.0001
976 INFLUENZA LIKE ILLNESS 5 0.0001
977 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
978 COVID-19 10 0.0001
979 DERMATITIS ATOPIC 3 0.0001
980 HAEMATOCHEZIA 3 0.0001
981 TREMOR 9 0.0001
982 PULMONARY EMBOLISM 5 0.0001
983 INCORRECT DOSE ADMINISTERED 12 0.0001
984 INJECTION SITE SWELLING 4 0.0001
985 BONE PAIN 3 0.0001
986 DRUG DEPENDENCE 8 0.0000
987 THROMBOSIS 4 0.0000
988 PRODUCT STORAGE ERROR 4 0.0000
989 BREAST CANCER 4 0.0000
990 NEUROPATHY PERIPHERAL 4 0.0000
991 DYSGEUSIA 3 0.0000
992 DRUG INTERACTION 6 0.0000
993 DRUG DOSE OMISSION 6 0.0000